Selecky Christobel sold IBRX

January 20, 2026 · Form 4 insider transaction

Selecky Christobel sold 25,000 shares of ImmunityBio, Inc. at $7.51 per share, a transaction worth $187.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
25,000
Price
$7.51
Total value
$187.7K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 20, 2026
Filing dateJanuary 21, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.; Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $7.50 to $7.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR
Selecky Christobel sold IBRX: January 20, 2026 | Insider Trading Screener